v3.23.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss $ (15,955,525) $ (6,881,048) $ (35,676,315) $ (37,379,153)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 9,406 141,892 586,109 397,440
Impairment of investment     50,000 589,461
Impairment of intangible assets     1,433,815 1,038,905
Impairment of goodwill   2,043,011 688,127
impairment of ROU     101,623
Accretion of debt discount and issuance cost 2,155,159 23,477 4,668,039 3,612,669
Share-based compensation 7,291,231 1,080,491 4,183,844 9,661,174
Shares issued for in process research and development     40,994
Derivative Expense 58,970 100,502
Loss on marketable securities     11,742
Currency Translation 129,971      
Bad debt expense 75,874 92,987 398,130 110,805
Settlement of vendor liabilities (23,589) (14,525) 265,717 (59,692)
Change in fair value of derivative liability (3,729) (3,729) 1,096,287
Gain on extinguishment of debt (147,256) 832,482 (1,304,677)
Non-cash lease expense 18,451 274,784 82,511
Reserve for obsolete inventory     399,058
Equity interest granted for other income     (123,710)
Equity in net loss from unconsolidated investment     16,413
Accounts receivable (80,804) (139,388) (755,907) (80,407)
Inventory 148,713 (136,213) (479,356) (39,182)
Prepaid expenses 68,216 (6,373) 86,155 (174,819)
Deposits and other assets (255,723) (195,749) (78,280) (527,115)
Operating lease right of use asset (39,886)      
Accounts payable and accrued liabilities 3,605,990 1,170,738 4,773,551 1,714,902
Deferred revenue (46,061) (22,483) 65,250 144,851
Operating lease liability (18,451) (26,146) (84,099)
Net Cash Used In Operating Activities (2,858,058) (5,037,179) (16,805,429) (20,518,807)
CASH FLOWS FROM INVESTING ACTIVITIES:        
Cash paid for minority investment in business     (325,000)
Cash paid for equity method investment     (510,000)
Cash paid for investments in marketable securities     (48,878)
Sale of marketable securities     37,135
Cash received from the Sale of non-controlling interest in OG Collection Inc.     750,000
Sale of digital assets     289,246
CASH FLOWS FROM FINANCING ACTIVITIES:        
Repayment of note payable - related party     (538,574)
Cash received for preferred series E and warrants     40,000
Purchase of treasury stock     (16,050)
Cash paid for property and equipment (44,927) (212,249) (95,935)
Cash received from the sale of minority interest in OG Collection Inc 250,000    
Cash consideration for acquisition 44,977 (31,679) (225,947)
Purchases of digital assets (51,000) (410,369) (11,241)
Net Cash Provided By (Used In) Investing Activities 250,000 (50,950) 373,206 (1,168,123)
Proceeds from the exercise of warrant 753,693 1,781,947 9,487,223
Net proceeds from issuance of notes 312,688 463,559 2,219,219 747,937
Repayment of notes (620,353) (932,888) (2,830,382) (456,233)
Proceeds from issuance of convertible note 2,125,000 8,391,905 3,610,491
Repayment of convertible notes (1,547,142) (1,863,315) (941,880)
Proceeds from issuance of common stock and warrants 1,050,000 4,997,301 5,722,300 5,666,951
Net Cash Provided By Financing Activities 2,073,886 4,527,972 13,405,624 17,615,915
Effect of exchange rate changes on cash   (4,950) (61,911) (41,038)
Net Change in Cash (534,172) (565,107) (3,088,510) (4,112,053)
Cash - Beginning of period 706,224 3,794,734 3,794,734 7,906,787
Cash - End of period 172,052 3,229,627 706,224 3,794,734
SUPPLEMENTARY CASH FLOW INFORMATION:        
Income taxes    
Interest 65,370 139,000 650 60,073
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:        
Conversion of marketable debt securities into equity securities 20,297    
Deemed dividend 6,337,246    
Shares issued for acquisition of NCI in consolidated subsidiaries 899,317    
Settlement of vendor liabilities     168,667
Beneficial conversion feature on convertible notes 2,000,000 2,008,227
Warrants issued with debt     3,149,270 1,665,682
Shares issued with debt     409,945
Issuance of common stock for prepaid services 213,750 69,000 141,150 226,500
Recognition of Right-of-use asset and corresponding operating lease liability     2,412,221
Deferred offering costs     4,225
Common stock and warrants issued upon conversion of notes payable $ 1,417,782 $ 173,456 1,061,088 5,156,994
Shares issued for acquisition     1,318,218
Reduction of ROU asset related to re-measurement of lease liability     135,086
Repayment of promissory notes from Australian R&D credits     $ 146,630